(Q70505780)
Statements
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma (English)
J A Sparano
R I Fisher
M Sunderland
K Margolin
M L Ernest
M Sznol
M B Atkins
K C Micetich